ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,018.39
-0.34%
US Tech 100
16,872.80
-0.65%
Dow Jones
37,903.29
0.23%
Brent Oil
83.525
-2.76%
Bitcoin
57,416.40
-5.25%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. Orapi (ORAP) Quote

Orapi

Orapi (ORAP)

Orange.
Orange.
Orange.
Orange.
6.28
0.00
(0.00%)
Closed May 01 11:30AM
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
6.28
Bid
6.04
Ask
6.40
Volume
1,484
6.28 Day's Range 6.42
3.69 52 Week Range 7.00
Market Cap
41.721M
Previous Close
6.28
Open
6.40
Last Trade
57
@
6.28
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
3,593
Shares Outstanding
6,643,534
Dividend Yield
-
PE Ratio
-2.22
Earnings Per Share (EPS)
-2.83
Revenue
231.9M
Net Profit
-18.82M

About Orapi

Sector
Indl Inorganic Chemicals,nec
Industry
Indl Inorganic Chemicals,nec
Website
www.orapi.com
Headquarters
Venissieux, Rhone, Fra
Founded
1970
Orapi is listed in the Indl Inorganic Chemicals sector of the Euronext with ticker ORAP. The last closing price for Orapi was 6.28 €. Over the last year, Orapi shares have traded in a share price range of 3.69 € to 7.00 €.

Orapi currently has 6,643,534 shares outstanding. The market capitalization of Orapi is 41.72 € million. Orapi has a price to earnings ratio (PE ratio) of -2.22.

ORAP Latest News

More News

ORAPI : Mise à disposition du Rapport Financier Annuel 2023

ORAPI : Mise à disposition du Rapport Financier Annuel 2023 Communiqué de presse         Lyon – Saint-Vulbas, le 18 avril 2023 à 17h30 Mise à disposition du rapport financier annuel 2023...

April 18 2024
GlobeNewswire Inc.

ORAPI : CHIFFRE D’AFFAIRES T1 2024 - Recul des ventes de 2,1% à périmètre comparable

ORAPI : CHIFFRE D’AFFAIRES T1 2024 - Recul des ventes de 2,1% à périmètre comparable Communiqué de presse         Lyon – Saint-Vulbas, le 16 avril 2024 à 18h CHIFFRE D’AFFAIRES DU T1 2024...

April 16 2024
GlobeNewswire Inc.

ORAPI : Modalités de mise à disposition des documents préparatoires à l'Assemblée Générale mixte du 30 Avril 2024

ORAPI : Modalités de mise à disposition des documents préparatoires à l'Assemblée Générale mixte du 30 Avril 2024 Communiqué de presse         Lyon – Saint-Vulbas, le 9 avril 2024 à...

April 09 2024
GlobeNewswire Inc.

ORAPI - Droits de vote au 31.03.2024

ORAPI - Droits de vote au 31.03.2024  ORAPI      Date d'arrêté:31/03/2024  ARTICLE 223-16 du règlement général de l'AMF          Actions du capital6,643,534  Droits de vote théoriques...

April 08 2024
GlobeNewswire Inc.

ORAPI : AVIS DE REUNION ASSEMBLEE GENERALE MIXTE DU 30 AVRIL 2024

ORAPI : AVIS DE REUNION ASSEMBLEE GENERALE MIXTE DU 30 AVRIL 2024 Assemblée Générale Mixte du 30 avril 2024 Publication de l’avis de réunion Aux termes de l'avis de réunion paru le 25 mars...

March 25 2024
GlobeNewswire Inc.

ORAPI : Résultat de l'offre réouverte

ORAPI : Résultat de l'offre réouverte Communiqué de presse – Genas et Saint-Vulbas, le 11 mars 2024 Succès de l’offre publique d’achat visant les actions ordinaires de ORAPI avec plus...

March 11 2024
GlobeNewswire Inc.

Succès de l’offre publique d’achat visant les actions ordinaires de ORAPI avec plus de 89% du capital détenu par Groupe Paredes

Regulatory News: L’Autorité des marchés financiers (AMF) a publié ce jour les résultats définitifs de l’offre publique d’achat initiée par Groupe Paredes sur les actions ordinaires ORAPI (l’«...

March 11 2024
Business Wire

ORAPI - Droits de vote au 29.02.2024

ORAPI - Droits de vote au 29.02.2024  ORAPI      Date d'arrêté:29/02/2024  ARTICLE 223-16 du règlement général de l'AMF          Actions du capital6,643,534  Droits de vote théoriques...

March 06 2024
GlobeNewswire Inc.

Orapi : Fort repli de l’ensemble des résultats 2023

ROC* 2023 : 1.0% du CA (-50% vs 2022) Résultat net à -18,8M€ vs +0,8 M€ en 2022 Regulatory News: Orapi (Paris:ORAP) : Périmètre courant en M€   2021   2022 2023** Chiffre d’affaires 226,6 229,6...

March 05 2024
Business Wire

ORAPI : Résultats annuels 2023

ORAPI : Résultats annuels 2023 Communiqué de presse         Lyon – Saint-Vulbas, le 5 mars 2024 à 18h00 Fort repli de l’ensemble des résultats 2023 ROC* 2023 : 1.0% du CA (-50% vs...

March 05 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.22-3.384615384626.56.525.8629106.48227766DE
4-0.22-3.384615384626.56.565.8616706.49496325DE
12-0.4-5.98802395216.686.725.8635936.54183435DE
26-0.12-1.8756.475.8641856.48762862DE
522.3660.20408163273.9273.6948586.12335136DE
156-2.22-26.11764705888.58.53.6942746.11331425DE
2600.8816.29629629635.411.53.21125567.31075206DE

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
LUNGPulmonx Corporation
$ 9.50
(23.06%)
17.31k
BNAIBrand Engagement Network Inc
$ 2.50
(18.48%)
128.02k
ENVXEnovix Corporation
$ 7.67
(17.82%)
1.5M
VRMVroom Inc
$ 12.7499
(11.06%)
3.75k
CORTCorcept Therapeutics Inc
$ 26.39
(10.51%)
15.03k
RELYRemitly Global Inc
$ 14.00
(-20.18%)
140.56k
FRSHFreshworks Inc
$ 15.00
(-17.81%)
162.53k
ARAYAccuray Incorporated
$ 1.85
(-14.75%)
90.06k
ETSYEtsy Inc
$ 60.41
(-13.38%)
624.25k
DASHDoorDash Inc
$ 112.58
(-11.67%)
680.16k
LYFTLyft Inc
$ 15.80
(-0.38%)
5.07M
TLTiShares 20 plus Year Treasury Bond
$ 88.471
(-0.10%)
2.05M
SQQQProShares UltraPro Short QQQ
$ 12.20
(-0.16%)
1.76M
TQQQProShares UltraPro QQQ
$ 51.70
(0.19%)
1.76M
CTMXCytomX Therapeutics Inc
$ 4.96
(-3.31%)
1.7M

Discussion

View Full Feed
nowwhat2 nowwhat2 47 seconds ago
https://investorshub.advfn.com/uimage/uploads/2024/5/1/tipvfspy_555_1_capt_FED_narate_Americans.jpg
SPY
Avockil Avockil 51 seconds ago
As I already stated once before, I heart this information on the Fridays meeting in Antwerpen. Maybe you should ask the company, if there was a recording done on Saturday on Gent. On Friday we had no recording. Sorry, so I can only comment on what I've heart. Have a nice day.
NB
hubfan hubfan 57 seconds ago
Slow and steady wins the race. We'll see volume increase soon. Eyes peeled
AABB
biosectinvestor biosectinvestor 1 minute ago
Nature publication…. Could be just ahead.

That will likely change perception in the marketplace. I can’t say it will bring in institutions, but it could substantially change the narrative, overnight.
NWBO
nowwhat2 nowwhat2 1 minute ago
https://investorshub.advfn.com/uimage/uploads/2024/5/1/tipvfspy_555_1_capt_FED_narate_Americans.jpg
BTCUSD
GhosTraderX GhosTraderX 1 minute ago
The Real question is...

Will this run continue tomorrow...

Bought in mid day...

GhosT
RGF
Xunefox Xunefox 1 minute ago
🫵🤫🤫🤫🤫🤫🤫
ASKH
seve333 seve333 1 minute ago
Yeah I know its usually the worst I just did not think it would drop that much.
AMRN
Researchfyi Researchfyi 2 minutes ago
For Almost, Today LQMT YOY CLOSED DOWN 7.75%
LQMT
konshe konshe 2 minutes ago
Trading is better and better day by day. I feel that RDGL will break out 0.25 by Friday, Will reach $1 before IDE submission news out. Good luck for long holders, not flippers.
RDGL
Carjockey2 Carjockey2 2 minutes ago
Think he was looking for 2022/2023..
NSAV
Deportes Deportes 2 minutes ago
Thanks docset for helping us figure out wtfk is going on at ENZC.
ENZC
StocksNcash StocksNcash 2 minutes ago
https://twitter.com/AITXRAD/status/1785658465865928809?t=eEy-zh2032CUrX-Orygmkw&s=19
AITX
WALLnut WALLnut 2 minutes ago
Been here since December 2014. Financial freedom is upon us. Blessed!!



RDGL
RDGL
BadaBingPebble BadaBingPebble 2 minutes ago
Wow, sizable sell of today. Should be interesting to see what happens next. The company follow through on important stuff is head shaking IMO.
TONR
Involuntary-Recluse Involuntary-Recluse 2 minutes ago
Dude, that was confidential, only the packs new about that deal...😂
Sheesh, can't keep any secrets around here ;-)
ASKH
trendzone trendzone 3 minutes ago
The smell of a major pump is in the air.
PSYC
AngusPorter AngusPorter 3 minutes ago
That does make sense… but why 3 and 4
IPIX
newmedman newmedman 3 minutes ago
Oh lord, what has happened to these kids? I think they all live in hap's imaginary heaven
GhosTraderX GhosTraderX 3 minutes ago
Looks like APVO is coming off the bottom

Bought some EOD...

GhosT
APVO
StocksNcash StocksNcash 3 minutes ago
https://twitter.com/AITXRAD/status/1785658465865928809?t=2-mexqvgxCZcPz_XxdEMjw&s=19. AITX$
AITX
janice shell janice shell 3 minutes ago
Depressing.
Chartmaster Chartmaster 3 minutes ago
No problem, here's my record SINCE JAN 1, 2021 as you asked for:
Feb 5, 2021 The day my account hit over 1 Million $$$
https://investorshub.advfn.com/uimage/uploads/2024/4/17/gxjtrMILLION_DAY_-_EDIT.PNG
Feb 8, 2021
investorshub.advfn.com/uimage/uploads/2021/4/17/ojrxr581K
NSAV
BearRickPunch BearRickPunch 3 minutes ago
Well I know exactly what and who you are and that isn't going to change my mind at all as well. I'm just glad that most people coming onto this board can see the same about you as well.
UNVC
ShadowVolcano37 ShadowVolcano37 3 minutes ago
Research offers exciting prospects for improving immunotherapy's effectiveness against cancer
https://www.msn.com/en-us/news/other/immunotherapy-a-beacon-of-hope-in-cancer-treatment/ar-AA1nUdcB https://www.msn.com/en-us/news/other/immunotherapy-a-beacon-of-hope-in-cancer-treatment/

Your Recent History

EU
ORAP
Orapi
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved